Nuclear_JJ
factor_NN
of_IN
activated_VBN
T_NN
cells_NNS
contains_VBZ
Fos_NN
and_CC
Jun_NN
._.

The_DT
nuclear_JJ
factor_NN
NF-AT_NN
-LRB-_-LRB-
ref_NN
._.
1_LS
-RRB-_-RRB-
is_VBZ
induced_VBN
in_IN
T_NN
cells_NNS
stimulated_VBN
through_IN
the_DT
T-cell_NN
receptor\/CD3_NN
complex_NN
,_,
and_CC
is_VBZ
required_VBN
for_IN
interleukin-2_NN
-LRB-_-LRB-
IL-2_NN
-RRB-_-RRB-
gene_NN
induction_NN
._.

Although_IN
NF-AT_NN
has_VBZ
not_RB
been_VBN
cloned_VBN
or_CC
purified_VBN
,_,
there_EX
is_VBZ
evidence_NN
that_IN
it_PRP
is_VBZ
a_DT
major_JJ
target_NN
for_IN
immunosuppression_NN
by_IN
cyclosporin_NN
A_NN
-LRB-_-LRB-
CsA_NN
-RRB-_-RRB-
and_CC
FK506_NN
-LRB-_-LRB-
refs_NN
2-7_CD
-RRB-_-RRB-
._.

NF-AT_NN
induction_NN
may_MD
require_VB
two_CD
activation-dependent_JJ
events_NNS
:_:
the_DT
CsA-sensitive_JJ
translocation_NN
of_IN
a_DT
pre-existing_JJ
component_NN
and_CC
the_DT
CsA-resistant_JJ
synthesis_NN
of_IN
a_DT
nuclear_JJ
component_NN
._.

Here_RB
we_PRP
report_VBP
that_IN
the_DT
newly_RB
synthesized_VBN
nuclear_JJ
component_NN
of_IN
NF-AT_NN
is_VBZ
the_DT
transcription_NN
factor_NN
AP-1_NN
._.

We_PRP
show_VBP
that_IN
the_DT
inducible_JJ
nuclear_JJ
form_NN
of_IN
NF-AT_NN
contains_VBZ
Fos_NN
and_CC
Jun_NN
proteins_NNS
._.

Furthermore_RB
,_,
we_PRP
identify_VBP
a_DT
pre-existing_JJ
NF-AT-binding_JJ
factor_NN
that_WDT
is_VBZ
present_JJ
in_IN
hypotonic_JJ
extracts_NNS
of_IN
unstimulated_JJ
T_NN
cells_NNS
._.

On_IN
the_DT
basis_NN
of_IN
binding_NN
,_,
reconstitution_NN
and_CC
cotransfection_NN
experiments_NNS
,_,
we_PRP
propose_VBP
that_IN
activation_NN
of_IN
NF-AT_NN
occurs_VBZ
in_IN
at_IN
least_JJS
two_CD
stages_NNS
:_:
a_DT
CsA-sensitive_JJ
stage_NN
involving_VBG
modification_NN
and\/or_CC
translocation_NN
of_IN
the_DT
pre-existing_JJ
NF-AT_NN
complex_NN
,_,
and_CC
a_DT
CsA-insensitive_JJ
stage_NN
involving_VBG
the_DT
addition_NN
of_IN
newly_RB
synthesized_VBN
Fos_NN
or_CC
Fos\/Jun_NN
proteins_NNS
to_TO
the_DT
pre-existing_JJ
complex_NN
._.

